May 1, 2020
Although research has linked pre-existing intratumoral immune response—characterized by presence of tumor-infiltrating lymphocytes or cytotoxic effector T cells—with improve prognosis in early triple-negative breast cancer...
Read MoreMay 1, 2020
Evidence suggests that, despite increased public health efforts to discourage teens from using hazardous tobacco products, use of electronic nicotine delivery systems (ENDS) remains high, due in part to direct youth targeting by...
Read MoreMay 1, 2020
Despite research suggesting that mutation in ESR1 is an acquired mechanism of resistance to endocrine therapy (ET), the impact of this mutation on therapy response in primary breast cancer remains unclear. To better understand...
Read MoreMay 1, 2020
Although previous studies suggest objective responses with BRAF and MEK inhibitors in the majority of patients with BRAF-mutant melanoma, data also suggest that acquired resistance limits response durations with these drugs....
Read MoreMay 1, 2020
With prior research indicating that patients with cancer are generally more vulnerable to infections, study investigators felt systematic analysis of diverse cohorts of patients with cancer affected by COVID-19 were needed. The...
Read More
